222 related articles for article (PubMed ID: 24293464)
1. The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension.
Gaine S; Simonneau G
Eur Respir Rev; 2013 Dec; 22(130):487-94. PubMed ID: 24293464
[TBL] [Abstract][Full Text] [Related]
2. New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
Preston IR; Suissa S; Humbert M
Eur Respir Rev; 2013 Dec; 22(130):495-502. PubMed ID: 24293465
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
Studer SM; Gilkin RJ
Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
[TBL] [Abstract][Full Text] [Related]
4. Six-minute walk test in pulmonary arterial hypertension.
Demir R; Küçükoğlu MS
Anatol J Cardiol; 2015 Mar; 15(3):249-54. PubMed ID: 25880178
[TBL] [Abstract][Full Text] [Related]
5. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
Huang J; Mehta S; Mura M
Respiration; 2015; 89(5):365-73. PubMed ID: 25791910
[TBL] [Abstract][Full Text] [Related]
6. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
[TBL] [Abstract][Full Text] [Related]
7. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.
Farber HW; Miller DP; McGoon MD; Frost AE; Benton WW; Benza RL
J Heart Lung Transplant; 2015 Mar; 34(3):362-8. PubMed ID: 25312386
[TBL] [Abstract][Full Text] [Related]
8. The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis.
Vizza CD; Badagliacca R; Messick CR; Rao Y; Nelsen AC; Benza RL
Int J Cardiol; 2018 Mar; 254():299-301. PubMed ID: 29254882
[TBL] [Abstract][Full Text] [Related]
9. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
[TBL] [Abstract][Full Text] [Related]
10. Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.
Fritz JS; Blair C; Oudiz RJ; Dufton C; Olschewski H; Despain D; Gillies H; Kawut SM
Chest; 2013 Feb; 143(2):315-323. PubMed ID: 22814814
[TBL] [Abstract][Full Text] [Related]
11. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
Neal JE; Lee AS; Burger CD
Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
[TBL] [Abstract][Full Text] [Related]
12. Exercise as an end-point in pulmonary hypertension trials.
McCullagh B; Girgis RE
Int J Clin Pract Suppl; 2010 Jan; (165):4-6. PubMed ID: 19958394
[TBL] [Abstract][Full Text] [Related]
13. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials.
Savarese G; Paolillo S; Costanzo P; D'Amore C; Cecere M; Losco T; Musella F; Gargiulo P; Marciano C; Perrone-Filardi P
J Am Coll Cardiol; 2012 Sep; 60(13):1192-201. PubMed ID: 22995024
[TBL] [Abstract][Full Text] [Related]
14. Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension.
Sun H; Stockbridge N; Ariagno RL; Murphy D; Nelson RM; Rodriguez W
J Perinatol; 2016 Dec; 36(12):1029-1033. PubMed ID: 27416322
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.
Sanges S; Launay D; Rhee RL; Sitbon O; Hachulla É; Mouthon L; Guillevin L; Rottat L; Montani D; De Groote P; Cottin V; Magro P; Prévot G; Bauer F; Bergot E; Chabanne C; Reynaud-Gaubert M; Leroy S; Canuet M; Sanchez O; Gut-Gobert C; Dauphin C; Pison C; Boissin C; Habib G; Clerson P; Conesa F; Cordier JF; Kawut SM; Simonneau G; Humbert M
Ann Rheum Dis; 2016 Aug; 75(8):1457-65. PubMed ID: 26324844
[TBL] [Abstract][Full Text] [Related]
16. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of changes in exercise test variables in pulmonary arterial hypertension.
Groepenhoff H; Vonk-Noordegraaf A; van de Veerdonk MC; Boonstra A; Westerhof N; Bogaard HJ
PLoS One; 2013; 8(9):e72013. PubMed ID: 24039732
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis.
Degano B; Sitbon O; Savale L; Garcia G; O'Callaghan DS; Jaïs X; Humbert M; Simonneau G
Chest; 2010 Jun; 137(6):1297-303. PubMed ID: 20118205
[TBL] [Abstract][Full Text] [Related]
19. Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.
Billings CG; Hurdman JA; Condliffe R; Elliot CA; Smith IA; Austin M; Armstrong IJ; Hamilton N; Charalampopoulos A; Sabroe I; Swift AJ; Rothman AM; Wild JM; Lawrie A; Waterhouse JC; Kiely DG
J Heart Lung Transplant; 2017 Aug; 36(8):871-879. PubMed ID: 28579006
[TBL] [Abstract][Full Text] [Related]
20. Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
Ulrich S; Saxer S; Hasler ED; Schwarz EI; Schneider SR; Furian M; Bader PR; Lichtblau M; Bloch KE
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
